BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer. (2017)

First Author: Pishvaian MJ
Attributed to:  Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2017.40

PubMed Identifier: 28291774

Publication URI: http://europepmc.org/abstract/MED/28291774

Type: Journal Article/Review

Volume: 116

Parent Publication: British journal of cancer

Issue: 8

ISSN: 0007-0920